SLC6A3 and Parkinson disease: They were part of another study [26] which required a single Movement Disorder specialist to classify cases according to whether they have motor symptoms of PD that did not require treatment (optimized); required a change in oral therapies; were referred for DAT; had contraindications that prevented motor symptoms from being adequately treated (Figure 3c,d).